Biosistemak

2016

1. A model for active and healthy ageing with a rare genetic disease: Cystic fibrosis

   European Respiratory Journal, Vol. 47, Núm. 3, pp. 714-719

2. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

   Clinical and Translational Allergy, Vol. 6, Núm. 1

3. Analgesia basada en infusión continua de anestésico local a nivel interfascial tras cirugía de colon laparoscópico: Ensayo clínico

   Revista Espanola de Anestesiologia y Reanimacion, Vol. 63, Núm. 4, pp. 197-206

4. Análisis de coste-utilidad de un modelo de atención integrada a pacientes pluripatológicos basado en un ensayo clínico

   Gaceta Sanitaria, Vol. 30, Núm. 5, pp. 352-358

5. Association of social support, functional status, and psychological variables with changes in health-related quality of life outcomes in patients with colorectal cancer

   Psycho-Oncology, pp. 891-897

6. Ausencia de influencia de los niveles de ansiedad o depresión en la calidad de vida, tras intervención de prótesis de cadera o rodilla

   Revista argentina de clínica psicológica, Vol. 25, Núm. 1, pp. 91-98

7. Calidad de la Prescripción y Control de Enfermedades Crónicas en Atención Primaria

   Congreso de la Sociedad Española de Farmacéuticos de Atención Primaria (SEFAP) (21º. Granada. 2016)

8. Change in the Reference Values for Serum Vitamin B12: Impact on the Clinical Laboratory

   Clinical laboratory

9. Chronic obstructive pulmonary disease subtypes. transitions over time

   PLoS ONE, Vol. 11, Núm. 9

10. Colorectal cancer health services research study protocol: The CCR-CARESS observational prospective cohort project

    BMC Cancer, Vol. 16, Núm. 1

11. Cost-effectiveness analysis of newborn screening for sickle-cell disease in Spain

    Expert Opinion on Orphan Drugs, Vol. 4, Núm. 6, pp. 567-575

12. Cost-effectiveness analysis of simeprevir with daclatasvir for non-cirrhotic genotype-1b-naïve patients plus chronic hepatitis C

    Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 16, Núm. 2, pp. 285-294

13. Cost-effectiveness analysis of sofosbuvir-based regimens for chronic hepatitis C

    Economía y salud: boletín informativo, Núm. 86

14. Cost-effectiveness analysis of sofosbuvir-simeprevir regimens for chronic hepatitis C genotype 1 patients with advanced fibrosis

    Medicina Clinica, Vol. 146, Núm. 2, pp. 61-64

15. Cytotoxicity of Au, ZnO and SiO2 NPs using in vitro assays with mussel hemocytes and gill cells: Relevance of size, shape and additives

    Nanotoxicology, Vol. 10, Núm. 2, pp. 185-193

16. DG connect funded projects on information and communication technologies (ICT) for old age people: Beyond Silos, CareWell and SmartCare

    Journal of Nutrition, Health and Aging, Vol. 20, Núm. 10, pp. 1024-1033

17. Determinants of change in physical activity during moderate-to-severe copd exacerbation

    International Journal of COPD, Vol. 11, pp. 251-261

18. Development of a Telemetric System for Postoperative Follow-up of Vascular Surgery Procedures: In Vitro Model

    Journal of the American Heart Association, Vol. 5, Núm. 7

19. Discriminant indices for distinguishing thalassemia and iron deficiency in patients with microcytic anemia: A reply

    Clinical Chemistry and Laboratory Medicine

20. Economic evaluation of the breast cancer screening programme in the Basque Country: Retrospective cost-effectiveness and budget impact analysis

    BMC Cancer, Vol. 16, Núm. 1